Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$1.07/mo
Lower than 99% of peersNiche median $19/mo
Creators
BuyYourShare
No social account linked
Launched
2mo ago
2026-09-15 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    One digital ecosystem for shops, apps, community & P2P

    Sep 15 · 2mo agoLaunch page

    At the time: <5K visits/mo

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2019-08-01

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Mensile
Mensile 0,99 €
Trimestrale
Trimestrale 2,69 €
Annuale
Annuale 9,90 €

Trial: None · Observed 2026-11-08 · Source page

Entry price $1.07/mo, Lower than 99% of peers; “Marketplaces & Classifieds” median is $19/mo.View pricing benchmark

Pages & changes

Tracked since 2026-09-15

Key pages

Weekly snapshots

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does BuyYourShare 2.0 cost?
Mensile: Mensile 0,99 €; Trimestrale: Trimestrale 2,69 €; Annuale: Annuale 9,90 €. Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does BuyYourShare 2.0 get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is BuyYourShare 2.0 and what platforms does it support?
BuyYourShare 2.0 is catalogued under Marketplaces & Classifieds: Da dove vuoi iniziare? Supported platforms: Web.

Related products in this category

Commerce & Retail / Marketplaces & Classifieds

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.